Celerion’s clinical research operations in Belfast, Northern Ireland, and its clinical research and bioanalytical services operations in Lincoln, NE, have been certified by the Brazilian National Health Surveillance Agency (Agência Nacional de Vigilância Sanitária – ANVISA). ANVISA provides regulatory approval for drugs and other products seeking to enter the Brazilian market. “The approval of ANVISA continues to demonstrate the high quality work done at Celerion,” said Susan Thornton, presiden...